kinetin has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edamatsu, H; Gau, CL; Guo, L; Nemoto, T; Tamanoi, F | 1 |
| Bentke, A; Laidler, P; Małecki, JM; Ostrowska, B | 1 |
2 other study(ies) available for kinetin and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines.
Topics: Alkyl and Aryl Transferases; Apoptosis; Benzazepines; Caspases; Cell Line; Chromones; Cyclin-Dependent Kinases; Cytochrome c Group; Cytosol; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; HL-60 Cells; Humans; Kinetin; Mitochondria; Morpholines; Phosphorylation; Purines; Retinoblastoma Protein; Roscovitine | 2000 |
Cytochalasin D, LY294002 and olomoucine synergize in promoting death of melanoma cells through activation of caspase-3 and apoptosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Chromones; Cytochalasin D; Drug Synergism; Enzyme Activation; Humans; In Situ Nick-End Labeling; Kinetin; Melanoma; Morpholines; Skin Neoplasms; Staurosporine; Up-Regulation | 2010 |